Note: Ingredients listed on restricted chemical lists
EC/CAS
541-02-6
Name of the chemical
D5
Concentration
N/A
EC/CAS
208-764-9
Name of the chemical
Decamethylcyclopentasiloxane
Concentration
N/A
General Information
Revision date
2019-04-18
Product name
LBF Sterile Barrier Film Wipes
1.2.1 Relevant identified uses
To provide a skin barrier film
Manufacturer Name
CliniMed Ltd
Emergency telephone
+44 (0) 7881 012589 / +44 (0) 7471033553
Icons in SDS
Company Information
company name
CliniMed Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H400, H410, H411
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 This product is regulated as a medical device in accordance with Directive 93/42/EEC as amended and labelled accordingly. The product is assessed and supplied with a safety data sheet in accordance with Regulation (EC) no 1272/2008.
CLP CLASSIFICATION
Flammable liquids, Category 2 H225 - Highly flammable liquid and vapour Short-term (acute) aquatic toxicity, Category 1 H400 - Very toxic to aquatic life Long-term (chronic) aquatic hazard, Category 2 H411 - Toxic to aquatic life with long lasting effects
2.2 Label elements
The product is a medical device in EEA and therefore the labelling elements from the CLP regulations do not apply, according to Regulation (EC) No 1272/2008, Title I, Article 1, Section 5. The below illustrated pictograms, signal words and hazard statements are therefore only listed in the present SDS and not necessarily present on the product labelling.
Signal word
Danger
Hazard statements
H225 Highly flammable liquid and vapour. H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P210 - Keep away from heat/sparks/open flames/hot surfaces. - No smoking. P273 - Avoid release to the environment.
2.3 Other hazards
Vapours may form explosive mixture with air. Static-accumulating flammable liquid. This product contains decamethylcyclopentasiloxane (D5) that has been identified by the Member State Committee of ECHA as fulfilling the vPvB criteria laid down in Annex XIII to Regulation (EC) No 1907/2006. See Section 12 for additional information.